ANEB Prakiraan wutah bathi resik saben saham kanggo taun ngarep Anebulo Pharmaceuticals Inc

Lambang korporat lan logo Anebulo Pharmaceuticals (ANEB)

Anebulo Pharmaceuticals (ANEB) faces geopolitical risks regarding patent registration and raw material procurement. The company develops cannabinoid overdose antidotes, funding its R&D through raised capital. Its environmental profile is limited to laboratory waste control. The value is fixed at 0.00, which clearly demonstrates the historical trend of the n+1 profit forecast.

ANEB: Prakiraan wutah bathi resik saben saham ing taun ngarep Anebulo Pharmaceuticals Inc 04.07.2022 - 07.03.2026

Rincian analitis lan laporan data perusahaan Anebulo Pharmaceuticals Inc (ANEB)

- rega saham lan konsensus proyeksi valuasi:
Ringkesan analisis perusahaan:ANEB, Anebulo Pharmaceuticals Inc
Produk merek Anebulo Pharmaceuticals, Inc.

The indicator measures analysts' average earnings growth expectations by aggregating forecasts for the coming year to assess the asset's fundamental attractiveness. The metric is sensitive to daily adjustments in market expectations, allowing for the rapid capture of industry reactions to quarterly reports. The projected earnings dynamics for Anebulo Pharmaceuticals (ANEB) over the next year reflect risks associated with patent disputes and geopolitical barriers in drug registration.

Pesaing Anebulo Pharmaceuticals

INDV (indivior.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep collegiumpharma.com (COLL)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cronos Group (CRON)|Canopy Growth Corp - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep HITI (High Tide Inc)|Aurora Cannabis (ACB) - Prakiraan wutah bathi resik saben saham ing taun ngarep|achievelifesciences.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Skye Bioscience|Canndoc (INCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NTRB - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep NSRX|Prakiraan wutah bathi kanggo taun ngarep igcinc.us|Prakiraan wutah bathi kanggo taun ngarep MIRA|floragrowth.ca (FLGC) - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep IMCC (IM Cannabis Corp)|Dinamika bathi saben saham sing diarepake ing taun ngarep ADIL|Artelo Biosciences Inc. - Prakiraan wutah bathi kanggo taun ngarep|ENSC: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Titan Pharma (TTNP) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Greenlane Holdings - Dinamika bathi saben saham sing diarepake ing taun ngarep|INM (inmedpharma.com) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AKAN (Akanda Corp.)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Enveric Corp (ENVB)|Bright Green Corporation - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Hempacco Co., Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep